Suchergebnisse - "Schetelig, J"

PubPharm (4)

1

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Röllig, C. | Kramer, M. | Gabrecht, M. | +26

2

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Thiel, A. | Schetelig, J. | Pönisch, W. | +19

3

Hematopoietic cell transplantation in patients with intermediate and high-risk AML : results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

enthalten in: Leukemia | 2015

von Schetelig, J. | Schaich, M. | Schäfer-Eckart, K. | +23

4

Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia

enthalten in: Leukemia | 2013

von Stölzel, F. | Platzbecker, U. | Mohr, B. | +9

1
[1]